NCT04293224

Brief Summary

This study, at the Western Human Nutrition Research Center (WHNRC), will focus on whether or not achieving and maintaining a healthy body weight is the most important health promoting recommendation of the Dietary Guidelines for Americans (DGA).The investigators hypothesize that improvement in cardiometabolic risk factors resulting from eating a DGA style diet will be greater in people whose energy intake is restricted to result in weight loss compared to those who maintain their weight. The investigators further propose that during a state of energy restriction, a higher nutrient quality diet such as the DGA style diet pattern, will result in greater improvement in cardiometabolic risk factors compared to a typical American diet (TAD) pattern that tends to be lower nutrient quality (more energy-dense and less nutrient-rich.)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
5mo left

Started Aug 2022

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Aug 2022Sep 2026

First Submitted

Initial submission to the registry

February 27, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 3, 2020

Completed
2.4 years until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

3.9 years

First QC Date

February 27, 2020

Last Update Submit

April 24, 2026

Conditions

Keywords

Dietary Guidelines for AmericansPhysical Activity for AmericansMediterranean DietControlled FeedingWomenPreDiabetesMetabolic SyndromeCognitive FunctionStress, PhysiologicalExecutive FunctionCardiovascular DiseasesCardiovascular Risk FactorEating BehaviorGlucose IntoleranceMetabolomic ProfilingMetabolic flexibilityGut MicrobiomeGenome TestingPrehypertensionInsulin ResistanceInsulin SensitivityHypertriglyceridemicWaist to Hip RatioAllostatic LoadPhysiology

Outcome Measures

Primary Outcomes (1)

  • Change in body weight

    Body weight will be measured to the nearest 0.1 kg using a calibrated electronic scale.

    Measured weekly for weeks 1 through 10, and weeks 13, 17, 21, 24 and 28

Secondary Outcomes (65)

  • Height

    Week 1

  • Change in body mass index

    Measured weekly for weeks 1 through 10, and weeks 13, 17, 21, 24 and 28

  • Change in body water (via InBody)

    Week 1, 10, 28

  • Change in body fat (via DEXA scan)

    Week 1, 10, 28

  • Change in waist circumference

    Week 1, 10, 28

  • +60 more secondary outcomes

Study Arms (3)

DGA Mediterranean diet pattern, energy balance

EXPERIMENTAL

Diet plan focused on energy balance (meets calorie needs), emphasizes fruits, vegetables and whole grains and limits calories from added sugars and saturated fats and reduces sodium intake per Dietary Guidelines for Americans (DGA) recommendations.

Other: DGA Mediterranean diet pattern, energy balance

DGA Mediterranean diet pattern, negative energy balance

EXPERIMENTAL

Negative energy balance (\~25% calorie reduction compared to needs), emphasizes fruits, vegetables and whole grains and limits calories from added sugars and saturated fats and reduces sodium intake per Dietary Guidelines for Americans (DGA) recommendations.

Other: DGA Mediterranean diet pattern, negative energy balance

TAD diet pattern

EXPERIMENTAL

Typical American Diet (TAD) with negative energy balance (\~25% calorie reduction compared to needs) which mimics intake of fruits, vegetables, whole grains, added sugars, saturated fats and sodium based on data from What We Eat in America (WWEIA).

Other: TAD diet pattern, negative energy balance

Interventions

Foods and beverages will be provided for participants for eight weeks. During the controlled feeding portion of the study the DGA Mediterranean diet pattern will be based on the Table A7-1 of the 2015 Dietary Guidelines for Americans which outlines daily nutritional goals for age-sex groups based on Dietary Reference Intakes (DRI) and dietary guidelines recommendations.

DGA Mediterranean diet pattern, energy balance

Foods and beverages will be provided for participants for eight weeks. During the controlled feeding portion of the study the DGA Mediterranean diet pattern will be based on the Table A7-1 of the 2015 Dietary Guidelines for Americans which outlines daily nutritional goals for age-sex groups based on Dietary Reference Intakes (DRI) and dietary guidelines recommendations

DGA Mediterranean diet pattern, negative energy balance

Foods and beverages will be provided for participants for eight weeks. During the controlled feeding portion of the study the be based on evidence collected from What We Eat in America (WWEIA) data. Based on this data the participants will be provided a diet that reflects American dietary trends.

TAD diet pattern

Eligibility Criteria

Age19 Years - 64 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Body Mass Index (BMI) 23-39.9 kg/m2 or 32-50% body fat percentage
  • Willingness to have blood drawn
  • The criteria listed above and at least one of the following: Fasting glucose ≥100 mg/dL but \<126 mg/dL or Fasting triglyceride ≥125 mg/dL or HDL-cholesterol ≤50 mg/dL or Blood Pressure (BP): Systolic BP ≥130 mmHg or Diastolic BP ≥85 mmHg or Hemoglobin A1C ≥ 5.7 and \<6.5%

You may not qualify if:

  • Active participation in another research study
  • Tested positive for COVID-19 within the past 10 days
  • Been in close contact with a COVID-19 positive person within the past 14 days
  • Blood Pressure (BP): Systolic BP ≥140 mmHg or Diastolic BP ≥90 mmHg
  • LDL cholesterol ≥190 mg/dL
  • Triglycerides ≥500 mg/dL
  • Current use of smoking or chewing tobacco, e-cigarettes, cigars, vaping, cannabis or other use of nicotine containing products (within the past 6 months)
  • Current use of dietary supplements and/or unwillingness to cease intake of dietary supplements
  • Vegan or vegetarian lifestyle or any other dietary restrictions that would interfere with consuming the intervention foods and beverages (including dietary intolerances, allergies and sensitivities)
  • Unwillingness to consume intervention foods and beverages
  • Engage in more than moderate drinking (\> 1 drink serving per day) or binge drinking (4 drinks within two hours).
  • Unwillingness to cease alcohol intake as required for specific duration of the study
  • Excessive intake of caffeine containing products (excessive defined as ≥ 400 mg/day)
  • Unwillingness to refrain from caffeine intake on lab visit days.
  • Intentional weight change of ≥5% of body weight within 6 months of entry into the study
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC Davis, Western Human Nutrition Research Center

Davis, California, 95616, United States

RECRUITING

Related Publications (1)

  • Krishnan S, Adams SH, Allen LH, Laugero KD, Newman JW, Stephensen CB, Burnett DJ, Witbracht M, Welch LC, Que ES, Keim NL. A randomized controlled-feeding trial based on the Dietary Guidelines for Americans on cardiometabolic health indexes. Am J Clin Nutr. 2018 Aug 1;108(2):266-278. doi: 10.1093/ajcn/nqy113.

    PMID: 30101333BACKGROUND

Related Links

MeSH Terms

Conditions

ObesityBody WeightPrediabetic StateMetabolic SyndromeCardiovascular DiseasesFeeding BehaviorGlucose IntolerancePrehypertensionInsulin Resistance

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesEndocrine System DiseasesHyperinsulinismBehavior, AnimalBehaviorHyperglycemiaVascular Diseases

Study Officials

  • Kevin D Laugero, PhD

    USDA, Western Human Nutrition Research Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Beverly Miller, BS, RDN

CONTACT

Ellen Bonnel, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2020

First Posted

March 3, 2020

Study Start

August 1, 2022

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Anonymized metabolomics data will be deposited on Metabolomics Work Bench (https://www.metabolomicsworkbench.org/), a national and international repository for metabolomics data and metadata, developed in support of the National Institutes of Health (NIH) Common Fund Metabolomics Program and housed at the San Diego Supercomputer Center (SDSC), University of California, San Diego. Archived data will include raw data files, quality assurance data, final analytical data, and associated experimental metadata including experimental group assignments, anthropometric, physiological and clinical measures.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
Immediately following publication. No end date.
Access Criteria
Anyone who wishes to access the data.

Locations